Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,146 public trials 6,477 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

NCT05916313

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • University of California Irvine Orange, California, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Salzburg Cancer Research Institute Salzburg, Austria
  • Universitätsklinikum Frankfurt Frankfurt, Germany
View Trial Details
Recruiting

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

NCT06263231

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • University of California Los Angeles (UCLA) - Santa Monica Cancer Care Santa Monica, California, United States
  • Yale School of Medicine - Smilow Cancer Hospital - Yale - New Haven Hospital Location New Haven, Connecticut, United States
View all 17 locations
View Trial Details
Recruiting

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

NCT05057702

Conditions
Ependymoma, Ependymoma Malignant, Ependymoma of Brain, +12 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View Trial Details

Related conditions